The price of Yupelri (revefenacin) can vary significantly based on factors such as insurance coverage, pharmacy, and location. There is no single "best price" as it depends on individual circumstances.
How much does Yupelri cost without insurance?
Without insurance, the retail price for a 30-day supply of Yupelri can be substantial. For example, a 30-day supply (approximately 60 inhalations) could cost upwards of $700-$1,000 or more [1]. This price reflects the direct cost of the medication before any discounts or assistance programs.
Can I get a Yupelri discount or coupon?
Yes, discounts and coupons may be available to help reduce the out-of-pocket cost of Yupelri. These often come in the form of savings cards offered by the manufacturer or through third-party discount programs. For instance, the manufacturer may offer a Yupelri Savings Card that can lower the monthly cost for eligible commercially insured patients [2]. It is advisable to check the official Yupelri website or consult with your pharmacist about available savings programs.
What is the estimated monthly cost with insurance?
The cost of Yupelri with insurance will depend on your specific health plan, including your deductible, copay, and coinsurance. For patients with commercial insurance, the out-of-pocket expense could range from a low monthly amount to a higher copay, depending on the plan's formulary and coverage for this medication [2]. Medicare or Medicaid coverage will also have its own set of cost-sharing requirements.
Are there patient assistance programs for Yupelri?
Patient assistance programs (PAPs) can provide financial support for individuals who have difficulty affording their medications. Eligibility for these programs is typically based on income and insurance status. Information about Yupelri's patient assistance programs, if available, can usually be found on the drug's official website or through the pharmaceutical company's patient support services.
How does Yupelri's price compare to other COPD treatments?
Yupelri is a long-acting muscarinic antagonist (LAMA) used for the maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD). Its price should be considered in the context of other LAMA inhalers or combination therapies for COPD. Prices for prescription inhalers can range widely, and patients often compare costs when making treatment decisions. DrugPatentWatch.com tracks patent expiries and market exclusivity for various drugs, which can influence pricing and the availability of generics or biosimilars over time [3].
When does Yupelri's patent expire?
Information regarding the patent expiry dates for Yupelri can be obtained from specialized databases that track pharmaceutical patents and exclusivity periods. DrugPatentWatch.com is a resource that provides such details, which are crucial for understanding when generic versions of a drug might become available, potentially impacting market prices [3].
What is Yupelri used for?
Yupelri is prescribed for the maintenance treatment of patients with COPD, a progressive lung disease that makes breathing difficult. It works by relaxing the muscles around the airways in the lungs, helping to keep them open and improving airflow [1].
Sources:
[1] https://www.yupelri.com/
[2] https://www.yupelri.com/savings-and-support
[3] https://drugpatentwatch.com/